Senior insider sale
Chief Executive Officer at LEGEND BIOTECH CORP — senior position signals high conviction
$1.73M
45.77K shares
What this filing means
HUANG YING plans to sell 45.77K shares of LEGEND BIOTECH CORP valued at approximately $1.73M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/23/2025ACC: 0001959173-25-004712
DirectorOfficer· Chief Executive Officer
Since Mar 2026
45.77K
Shares to sell
$1.73M
Approx. market value
15.29K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months2
Option Granted - 03/29/2021
Cash
7/23/2025
3.93KOption Granted - 07/22/2019
Cash
7/23/2025
11.36KTotal acquired15.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/23/2025 | Option Granted - 03/29/2021 Cash | 3.93K | — |
7/23/2025 | Option Granted - 07/22/2019 Cash | 11.36K | — |
| Total | 15.29K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
12.12K
Market value
$408.7K
6/25/2025
—Completed
Units to sell
11.81K
Market value
$408.6K
6/24/2025
—Completed
Units to sell
6.55K
Market value
$226.2K
5/1/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
15.29K
Market value
$688.7K
7/23/2025
Total
Units
45.77K
Value
$1.73M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2025 | 12.12K | $408.7K | — | Completed |
6/24/2025 | 11.81K | $408.6K | — | Completed |
5/1/2025 | 6.55K | $226.2K | — | Completed |
| Planned — Approximate Date | ||||
7/23/2025 | 15.29K | $688.7K | NASDAQ | Planned |
| Total | 45.77K | $1.73M | ||